Skip to main content
S 641 119th Congress Senate Health Administrative law and regulatory procedures Canada Department of Health and Human Services Drug safety, medical device, and laboratory regulation Government information and archives Prescription drugs Trade restrictions

Safe and Affordable Drugs from Canada Act of 2025

Introduced: February 19, 2025 Introduced by: Klobuchar, Amy Democratic · Minnesota See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 19, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb 19, 2025
Introduced in Senate
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Jul 27, 1995 Senate · vote #338 On Passage of the Bill S. 641 Passed 973 See who voted →
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Safe and Affordable Drugs from Canada Act of 2025

This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.

Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.

An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs.

The FDA must publish a list of approved Canadian pharmacies on its website.

What's happening now February 19, 2025

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 641: Safe and Affordable Drugs from Canada Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-S-641/
MLA
"S. 641: Safe and Affordable Drugs from Canada Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-641/.
Bluebook (legal)
S. 641, 119th Cong. (2026), https://openamerica.io/bill/119-S-641/.
Markdown link
[S. 641: Safe and Affordable Drugs from Canada Act of 2025](https://openamerica.io/bill/119-S-641/)
Report a problem